Authors: Cruz Villagrán Claudia, Schumacher Jim, Donnell Robert, Dhar Madhu S
Journal: Frontiers in veterinary science
Summary
# Editorial Summary: Equine Bone Marrow-Derived Mesenchymal Stromal Cells for Nerve Regeneration Whilst mesenchymal stromal cell (MSC) transplantation has demonstrated promise for peripheral nerve repair in laboratory models, its application in equine medicine remains unexplored. Villagrán and colleagues investigated whether equine bone marrow-derived MSCs could be differentiated into Schwann-like cells in vitro and subsequently promote regeneration of transected peripheral nerve in vivo. Equine MSCs from three donors successfully adopted the morphological and protein characteristics of Schwann cells (positive for GFAP and S100b markers) within 7 days of culture in specialised differentiation medium; however, when implanted around the fascia of a transected ramus communicans nerve in three healthy horses, histological examination at 45 days post-injury revealed no regenerative response, with no significant differences between MSC-treated and saline-control nerves. These findings suggest that whilst the in vitro differentiation protocol was effective, the surgical delivery method, implantation location, or timeframe may be suboptimal for promoting functional nerve regeneration in equine peripheral nerves, highlighting the need for refined protocols before this approach can be considered clinically viable for treating nerve injuries in horses.
Read the full abstract on PubMed
Practical Takeaways
- •While equine MSCs can be successfully differentiated into Schwann-like cells in the laboratory, this in vitro success did not translate to functional nerve regeneration in vivo at 45 days post-injury.
- •Current MSC delivery methods and timing may be suboptimal; practitioners should await further research on improved implantation techniques before considering this as a clinical treatment for nerve injuries.
- •This preliminary negative result highlights that stem cell therapies require careful refinement of delivery, dosage, and timing before clinical application in equine nerve injury cases.
Key Findings
- •Equine bone marrow-derived MSCs successfully differentiated into Schwann-like cells in vitro within 7 days, demonstrating appropriate morphological and protein characteristics (GFAP and S100b markers).
- •MSC-implanted nerves showed no histological evidence of regeneration at 45 days post-transection in vivo.
- •No significant histological differences were observed between MSC-treated and saline control nerves at 45 days, suggesting MSC implantation alone was insufficient for nerve regeneration in this model.